3PBIOVIAN and Universidad CEU San Pablo formalize an alliance to promote the development of new professionals in health biotechnology December 9, 2025 Read more >
3PBIOVIAN, awarded at the Cegos Awards 2025 for its AI-driven talent management model October 20, 2025 Read more >
Elena Erroba Assumes Representation of 3PBIOVIAN on the AseBio Board of Directors May 27, 2025 Read more >
3PBIOVIAN Unveils Two Groundbreaking Technology Platforms for AAV and pDNA Manufacturing May 13, 2025 Read more >
3PBIOVIAN Awarded at the CDMO Leadership Awards 2025 in the Cell & Gene Therapy International Category April 1, 2025 Read more >
3PBIOVIAN Celebrates Its First Anniversary Leading the Future of Biotechnology February 12, 2025 Read more >
Eleva and 3PBIOVIAN sign strategic GMP manufacturing and technology alliance to boost capacity for Eleva’s platform and pipeline February 4, 2025 Read more >
3PBIOVIAN strengthens its Leadership team with the appointment of a Business Development Director for Advanced Therapies October 9, 2024 Read more >
3PBIOVIAN receives the Talent Acceleration Award at the 2024 BWB Awards in Boston September 25, 2024 Read more >
3PBIOVIAN strengthens its executive team with the appointment of three new directors September 19, 2024 Read more >
Rokote Laboratories signs an agreement with 3PBIOVIAN for GMP manufacturing of adenovirus vector-based COVID-19 vaccine August 29, 2024 Read more >